logo
Enko Chem Reports Breakthrough Field Trial Success for Next-Generation Graminicide Portfolio

Enko Chem Reports Breakthrough Field Trial Success for Next-Generation Graminicide Portfolio

Business Wire20-05-2025
MYSTIC, Conn.--(BUSINESS WIRE)--Enko Chem, Inc., a leading AgTech company developing breakthrough, sustainable crop protection products, today announced results from its latest European field trials of product candidates from a novel graminicide portfolio developed to tackle the growing threat of herbicide-resistant weeds in cereal crops. These trials specifically revealed exceptional control of blackgrass in winter wheat paired with outstanding crop safety. Earlier trials in other regions of the world have already shown success against a range of other problematic grass weeds.
As stricter environmental and safety standards reduce the availability of conventional herbicides, growers face fewer options for managing persistent weeds that significantly reduce crop yields. Enko's next generation graminicides are safe and sustainable potential replacements for older products that address the evolving needs of both growers and regulators.
The European field trials were conducted across the United Kingdom and France, where herbicide-resistant blackgrass is known to cause crop yield losses of up to 70% in severe cases. Enko's innovative chemistry demonstrated superior performance compared to existing commercial standards.
Prior to Europe, Enko's North American spring trials demonstrated efficacy against other problematic warm-season grasses including crabgrass, giant foxtail, and goosegrass, while Australian tests addressed the growing threat of resistant annual ryegrass. The European results build upon this foundation of success across diverse geographies and weed species.
'Our product candidates integrate seamlessly into existing cereal crop systems and deliver industry-leading control of resistant grass species,' says Tony Klemm, CEO of Enko. 'Growers urgently need new, effective, and environmentally responsible chemistry. This graminicide portfolio is proof that a smarter discovery model delivers solutions – addressing key challenges like blackgrass resistance while advancing safe, sustainable agriculture.'
With development efforts reaching key benchmarks, Enko is actively collaborating with multiple industry partners to accelerate the global commercialization of its products.
For more information about Enko and its pipeline of crop protection solutions, visit www.enko.ag.
About Enko®
Enko (Enko Chem Inc.) designs safe and sustainable solutions to farmers' biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers' evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Gates Foundation, Anterra Capital, DYDK Capital, Nufarm, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit www.enko.ag.
Enko's Cautionary Statement Regarding Forward-Looking Statements
This press release contains forecasts, projections, goals, plans, and other forward-looking statements. Such forward-looking statements are based on Enko's assumptions, estimates, outlook, and other judgments made in light of information available at the time of preparation of such statements and involve both known and unknown risks and uncertainties. Accordingly, plans, goals, and other statements may not be realized as described, and actual financial results, success/failure or progress of development, and other projections may differ materially from those presented herein. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Enko's control and that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Enko does not intend to update any forward-looking statements appearing herein in the event of changing circumstances or otherwise, and such statements are current only as of the date they are made.
©Enko Chem, Inc., 62 Maritime Drive, Mystic, CT 06355 USA
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Air France-KLM to take majority stake in Scandinavian airline SAS
Air France-KLM to take majority stake in Scandinavian airline SAS

New York Post

time2 hours ago

  • New York Post

Air France-KLM to take majority stake in Scandinavian airline SAS

Air France-KLM plans to increase its stake in Scandinavian airline SAS to 60.5%, the latest step towards consolidating Europe's fragmented airline sector as carriers seek to strengthen their position against rivals. The Franco-Dutch airline group said on Friday it intended to increase its stake from 19.9% currently by acquiring the stakes held by top shareholders Castlelake and Lind Invest. The purchase, subject to regulatory clearances, is expected to close in the second half of 2026, Air France-KLM said. Advertisement 3 Air France-KLM is looking to increase it's stake in Scandinavian carrier SAS to 60.5% from 19.9%. EPA The value of the investment would be determined at closing, based on SAS's latest financial performance, including core earnings and net debt, the company said. It declined to give details on those metrics. Air France-KLM expects to generate 'three-digit million' euros in synergies from raising its SAS stake, finance chief Steven Zaat told analysts on a call. Advertisement Zaat said the deal would be funded from cash or a 'plain vanilla bond' and would not impact the drive to reduce the group's hybrid debt. 'We have ample room for it,' he said. SAS welcomed Air France-KLM's announcement. 'European consolidation had to happen further, and we're very happy to be part of that,' SAS CEO Anko van der Werff told Danish broadcaster TV2. 3 The Danish government will keep its 26.4% stake in SAS and its seats on the board. REUTERS Advertisement 'In the current setup where Air France-KLM is a 19.9% shareholder, they're still a competitor,' he said. 'With the new stake, going above 50%, we can really tap into all of those synergies and offer those benefits to customers.' SAS said it would continue to invest in its fleet and network. In 2023, Air France-KLM said it would invest about $144.5 million for its initial SAS stake, boosting its presence in Sweden, Denmark and Norway with the option to become a controlling shareholder after a minimum of two years, subject to conditions. SAS exited from Chapter 11 bankruptcy protection in August 2024. Advertisement 3 Air France-KLM CEO Ben Smith. Bloomberg via Getty Images The two carriers have already had a commercial cooperation since summer 2024. Control of SAS would allow Air France-KLM to expand in the Scandinavian market and create additional value for shareholders, Air France-KLM said in a statement. 'Following their successful restructuring, SAS has delivered impressive performance, and we are confident that the airline's potential will continue to grow through deeper integration within the Air France-KLM Group,' said Air France-KLM CEO Ben Smith. The deal comes as executives seek more consolidation in Europe's fragmented airline industry, which they say is needed to compete with U.S. and Middle Eastern rivals. SAS has 138 aircraft in service and carried more than 25 million passengers last year, generating revenues of 4.1 billion euros ($4.8 billion). Air France-KLM group would have a majority of seats on the board of directors, while the Danish state will keep its 26.4% stake in SAS and its seats on the board.

Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare
Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare

Business Wire

time2 hours ago

  • Business Wire

Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare

SAN FRANCISCO--(BUSINESS WIRE)--Today, Lively, Inc. marks the signature of the 'One Big Beautiful Bill' (OBBB) into law, a major bill that expands access and flexibility for Health Savings Accounts (HSAs). Under the new law, millions of Americans enrolled in Bronze or Catastrophic ACA plans are now eligible to contribute to HSAs starting January 1, 2026, and key innovations like telehealth services and Direct Primary Care are officially HSA-qualified expenses. Game-Changing HSA Reforms Just Passed—Here's What It Means for Healthcare: Landmark legislation enables HSA use with Bronze/Catastrophic ACA plans, telehealth, and direct primary care—bringing healthcare savings into the modern era. Share Lively, a top-rated health and lifestyle benefits platform* known for building the modern Health Savings Account (HSA), is uniquely positioned to support individuals, employers, and brokers navigating this new era. Lively's platform already connects with over 95% of U.S. health plans and integrates seamlessly with Direct Primary Care models and virtual-first providers. 'In a world of rising out-of-pocket costs, HSAs are the most powerful way to take control of US consumer healthcare finances. This isn't just a policy shift—it's a redefinition of how Americans can save, spend, and stay healthy," said Alex Cyriac, CEO and co-founder of Lively. 'At Lively, we've built a platform that's flexible, intelligent, and ready for this next generation of benefits.' What's Changing: HSA Eligibility Opens for Millions of Americans: Enrollees in Bronze and Catastrophic ACA plans are now eligible and can contribute to HSAs. Modern Care Models Included: HSA funds can be used for Direct Primary Care arrangements. Telehealth Flexibility Made Permanent: First-dollar coverage for telehealth services no longer disqualifies HSA status. How Lively Helps: No Hidden Fees - Your healthcare shouldn't come at a hidden cost — Lively HSAs are free for individuals and families. Get Started in Minutes: Confirm your eligibility and open an HSA account instantly. Smart Claim Sync: Automatically syncs with employee health plan data, including high-deductible, Bronze, and Catastrophic plans. Built for Innovation: Already supports virtual-first, Direct Primary Care (DPC), and hybrid health plan designs. About Lively Lively is the health and lifestyle benefits provider that gets it right. Our solutions are designed to take the guesswork out of managing benefits and drive efficiency for HR teams. Our innovative platform combines robust features with unparalleled service, to make maximizing your benefits as simple as it should be. Lively currently offers HSA, FSA, HRA, COBRA, Direct Bill, Commuter, Lifestyle Spending Accounts, and Medical Travel Accounts.

OLO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olo Inc.
OLO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olo Inc.

Business Wire

time2 hours ago

  • Business Wire

OLO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olo Inc.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Olo Inc. (NYSE: OLO) to Thoma Bravo. Under the terms of the proposed transaction, shareholders of Olo will receive $10.25 in cash for each share of Olo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store